Literature DB >> 19944125

Plasma ghrelin and obestatin levels are increased in spontaneously hypertensive rats.

Zhao-Feng Li1, Zhi-Fu Guo, Jiang Cao, Jian-Qiang Hu, Xian-Xian Zhao, Rong-Liang Xu, Xin-Miao Huang, Yong-Wen Qin, Xing Zheng.   

Abstract

Obestatin, encoded by the same gene as ghrelin, was first described as a physiological opponent of ghrelin. We investigated fasting plasma ghrelin and obestatin levels in spontaneously hypertensive rats and Wistar-Kyoto rats. We found that ghrelin levels, obestatin levels and the ratio of ghrelin to obestatin were significantly higher in spontaneously hypertensive rats than Wistar-Kyoto rats. Systolic blood pressure and diastolic blood pressure were positively correlated; however, heart period and baroreflex sensitivity were negatively correlated with ghrelin levels. Systolic blood pressure was positively correlated, whereas baroreflex sensitivity was negatively correlated with obestatin levels. In addition, systolic blood pressure was a significantly independent variable of ghrelin levels, obestatin levels, and the ghrelin to obestatin ratio in a multiple regression analysis. Our data suggests that there is a disturbance of ghrelin and obestatin in the circulation of spontaneously hypertensive rats and the ghrelin/obestatin system might play a role in blood pressure regulation. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944125     DOI: 10.1016/j.peptides.2009.11.018

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling.

Authors:  Andrew J Agnew; Emma Robinson; Carmel M McVicar; Adam P Harvey; Imran H A Ali; Jennifer E Lindsay; Denise M McDonald; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Biological effects of obestatin.

Authors:  Jiang-Bo Li; Akihiro Asakawa; Kaichun Cheng; Yingxiao Li; Huhe Chaolu; Minglun Tsai; Akio Inui
Journal:  Endocrine       Date:  2011-03-20       Impact factor: 3.633

Review 3.  Diverse and Complementary Effects of Ghrelin and Obestatin.

Authors:  Daniel Villarreal; Geetali Pradhan; Yu Zhou; Bingzhong Xue; Yuxiang Sun
Journal:  Biomolecules       Date:  2022-03-29

4.  Obestatin regulates cardiovascular function and promotes cardioprotection through the nitric oxide pathway.

Authors:  Claudia Penna; Francesca Tullio; Saveria Femminò; Carmine Rocca; Tommaso Angelone; Maria C Cerra; Maria Pia Gallo; Iacopo Gesmundo; Alessandro Fanciulli; Maria Felice Brizzi; Pasquale Pagliaro; Giuseppe Alloatti; Riccarda Granata
Journal:  J Cell Mol Med       Date:  2017-07-26       Impact factor: 5.310

Review 5.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

6.  Increased sensitivity of the circadian system to temporal changes in the feeding regime of spontaneously hypertensive rats - a potential role for Bmal2 in the liver.

Authors:  Lenka Polidarová; Martin Sládek; Marta Nováková; Daniela Parkanová; Alena Sumová
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

7.  Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms.

Authors:  Manuela Aragno; Raffaella Mastrocola; Corrado Ghé; Elisa Arnoletti; Eleonora Bassino; Giuseppe Alloatti; Giampiero Muccioli
Journal:  Cardiovasc Diabetol       Date:  2012-10-15       Impact factor: 9.951

8.  Low serum concentration of obestatin as a predictor of mortality in maintenance hemodialysis patients.

Authors:  Ilia Beberashvili; Inna Sinuani; Ada Azar; Hadas Kadoshi; Gregory Shapiro; Leonid Feldman; Judith Sandbank; Zhan Averbukh
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

9.  Association between Hypertension, Antihypertensive Drugs, and Osteoporosis in Postmenopausal Syrian Women: A Cross-Sectional Study.

Authors:  Nermeen Hijazi; Zaynab Alourfi
Journal:  Adv Med       Date:  2020-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.